Dementia in Parkinson's disease (PD) is a frequent complication that often limits the efficacy of pharmacotherapy and may decrease survival. We propose that the majority of demented patients have Alzheimer's disease (AD) and dementia will be associated with the risk factors for the development of Alzheimer's disease (AD). Dementia in the remaining patients is a late effect of PD and may be due to increased exposure or a critical period of exposure to the risk factors responsible for PD. Using a case-control approach, we will collect genetic and environmental risk factor information in 150 demented PD patients, 150 nondemented PD patients and 300 healthy elderly patients, all previously identified and examined neurologically and neuropsychologically. Reliable interviews for putative environmental risk factors for both PD and dementia in PD will be developed. All patients will have their blood screened for mutations in the coding and the promoter regions of the amyloid precursor protein (APP) gene and for low level mosaicism for trisomy 21. A cell bank will be established for future investigations. A reliable family history interview will be completed in all participants for ascertainment of AD and PD in first-degree relatives of PD patients and controls. Familial aggregation of AD and PD will be assessed by comparing cumulative incidence of AD and PD in first-degree relatives of PD patients with and without dementia, with and without APP gene mutations and with onset of motor manifestations <65 and >65. Potential gene-environment interactions will be explored by comparing PD patients with and without a family history of AD and PD, and the effects of environmental factors on the development of dementia. Statistical methods will be used to develop models to predict the development of dementia based on the significant risk factors from the preliminary analysis. Cumulative incidence of AD and PD in relatives will be examined with life table methods and rate ratios will be calculated using Cox proportional hazards modeling.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Unknown (R35)
Project #
5R35AG010963-07
Application #
6098466
Study Section
Project Start
1998-07-01
Project End
1999-05-31
Budget Start
Budget End
Support Year
7
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Aarsland, D; Kvaloy, J T; Andersen, K et al. (2007) The effect of age of onset of PD on risk of dementia. J Neurol 254:38-45
Fillenbaum, Gerda G; Burchett, Bruce M; Lee, Joseph H et al. (2003) Mortality and apolipoprotein E in African-American, and White elders: an attempted replication. Am J Med Genet A 119A:141-6
Levy, Gilberto; Tang, Ming-Xin; Cote, Lucien J et al. (2002) Do risk factors for Alzheimer's disease predict dementia in Parkinson's disease? An exploratory study. Mov Disord 17:250-7
Levy, G; Tang, M-X; Louis, E D et al. (2002) The association of incident dementia with mortality in PD. Neurology 59:1708-13
Levy, Gilberto; Jacobs, Diane M; Tang, Ming-Xin et al. (2002) Memory and executive function impairment predict dementia in Parkinson's disease. Mov Disord 17:1221-6
Levy, Gilberto; Schupf, Nicole; Tang, Ming-Xin et al. (2002) Combined effect of age and severity on the risk of dementia in Parkinson's disease. Ann Neurol 51:722-9
Singh, M (2001) Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 14:407-15
Lee, J H; Tang, M X; Schupf, N et al. (2001) Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet 103:121-7
Schupf, N; Kapell, D; Nightingale, B et al. (2001) Specificity of the fivefold increase in AD in mothers of adults with Down syndrome. Neurology 57:979-84
Mayeux, R; Small, S A (2000) Finding the beginning or predicting the future? Arch Neurol 57:783-4

Showing the most recent 10 out of 60 publications